术前LVEDP、CK-MB及UA水平对STEMI患者经皮冠状动脉介入术后死亡的预测价值

邸亚丽; 张红梅; 李霞; 纪征; 高翔; 孙淑娴; 杨立明; 张宇; 吴峥

doi:10.13201/j.issn.1001-1439.2020.10.015

术前LVEDP、CK-MB及UA水平对STEMI患者经皮冠状动脉介入术后死亡的预测价值

- 1. 唐山市工人医院心内科(河北唐山, 063000);
- 2. 唐山市工人医院党委工作部;
- 3. 首都医科大学附属北京安贞医院心内科北京市心肺血管疾病研究所
基金项目:
河北省2020年度医学科学研究课题计划(No:20201512)

详细信息

通讯作者: 纪征,E-mail:jizheng99@163.com

中图分类号: R541.4

收稿日期: 2020-06-04

Preoperative LVEDP, CK-MB, and UA levels in predicting the mortality of STEMI patients after percutaneous coronary intervention

- 1. Department of Cardiology;
- 2. Party Committee, Tangshan Gongren Hospital, Tangshan, Hebei, 063000, China;
- 3. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases

More Information

Corresponding author: JI Zheng, E-mail: jizheng99@163.com

Received Date: 04 June 2020

摘要

摘要: 目的:探究左心室舒张末期压力(LVEDP)、肌酸激酶同工酶(CK-MB)及尿酸(UA)水平对急性ST段抬高型心肌梗死(STEMI)患者经皮冠状动脉介入术(PCI)后死亡的预测价值。方法:连续性入选2017年2月—2019年3月在我院行PCI的STEMI患者,按照术后1年内生存状况分为死亡组(24例)和存活组(98例)。比较两组患者临床特点、生化指标、冠状动脉病变程度、心功能情况、Gensini积分以及LVEDP、CK-MB、UA水平,有统计意义者纳入Cox回归分析预后相关因素;并采用ROC曲线分析LVEDP、CK-MB及UA水平对STEMI患者介入术后死亡的预测价值。结果:与存活组比较,死亡组前壁心肌梗死比例更多,收缩压、舒张压、左心室射血分数(LVEF)水平较低,Gensini积分、LVEDP、CK-MB及UA水平明显升高(均P<0.05)。Logistic回归分析显示,收缩压、舒张压、LVEF为PCI后患者死亡的保护因素(OR=0.965、0.979、0.879,均P<0.05),Gensini积分、LVEDP、CK-MB及UA均为患者PCI后死亡的独立危险因素(OR=1.078、3.359、1.019、1.009,均P<0.05)。ROC曲线分析显示,LVEDP、CK-MB、UA单独预测介入术后死亡的曲线下面积(AUC)分别为0.973、0.819、0.625,敏感性分别为95.8%、83.3%、45.8%,特异性分别为94.4%、79.6%、91.7%。LVEDP、CK-MB、UA联合预测介入术后死亡的AUC为0.985,敏感性、特异性分别为99.1%、100.0%。结论:入院时收缩压、舒张压、LVEF为PCI后患者死亡的保护因素,Gensini积分、LVEDP、CK-MB及UA均为患者PCI后死亡的独立危险因素。LVEDP、CK-MB及UA联合检测对STEMI患者介入术后死亡的预测价值较高。
- 左心室舒张末期压力 /
- 肌酸激酶同工酶 /
- 尿酸 /
- ST段抬高型心肌梗死 /
- 术后死亡
Abstract: Objective: To explore the predictive value of left ventricular end diastolic pressure(LVEDP), creatine kinase isoenzyme(CK-MB), and uric acid(UA) levels for the mortality of patients with acute ST-segment elevation myocardial infarction(STEMI) after percutaneous coronary intervention(PCI). Method: From February 2017 to March 2019, STEMI patients who underwent PCI in our hospital were selected as the study objects. According to the survival status within one year after PCI, they were divided into the death group(n=24) and survival group(n=98). The clinical characteristics, biochemical indexes, degree of coronary artery disease, cardiac function, Gensini score, LVEDP, CK-MB, and UA levels between the two groups were compared. Those with statistical significance were included in Cox regression analysis to analyze the prognostic factors. The ROC curve was used to analyze the predictive value of LVEDP, CK-MB, and UA levels for the mortality of STEMI patients after intervention. Result: Compared with the survival group, the death group had higher proportion of anterior myocardial infarction, lower levels of systolic blood pressure, diastolic blood pressure, left ventricular ejection fraction(LVEF), and significantly higher Gensini score, levels of LVEDP, CK-MB, and UA(all P<0.05). Logistic regression analysis showed that systolic blood pressure, diastolic blood pressure, and LVEF were protective factors of death after PCI(OR=0.965, 0.979, 0.879, all P<0.05), Gensini score, LVEDP, CK-MB, and UA were all independent risk factors of death after PCI(OR=1.078, 3.359, 1.019, 1.009, all P<0.05). ROC curve analysis showed that the area under the curve(AUC) of LVEDP, CK-MB, and UA in predicting postoperative death were 0.973, 0.819, and 0.625, the sensitivity were 95.8%, 83.3%, and 45.8%, the specificity was 94.4%, 79.6%, and 91.7%, respectively; the AUC of combination of LVEDP, CK-MB, and UA in predicting postoperative death was 0.985, the sensitivity and specificity were 99.1% and 100.0%, respectively.Conclusion: Systolic blood pressure, diastolic blood pressure and LVEF are protective factors of death after PCI, Gensini score, LVEDP, CK-MB and UA are independent risk factors of mortality after PCI. The combined detection of LVEDP, CK-MB and UA has a high predictive value for the death of STEMI patients after PCI.
- left ventricle end-diastolic pressure /
- creatine kinase isoenzymes /
- uric acid /
- ST-elevation myocardial infarction /
- postoperative mortality

HTML全文

参考文献(14)

[1]	Al-Lamee R,Thompson D,Dehbi HM,et al.Percutaneous Coronary Intervention in Stable Angina(ORBITA):A Double-Blind,Randomized Controlled Trial[J].Lancet,2018,391(10115):31-40.
[2]	刘尚军,周祥群.海南南部地区候鸟人群与本地人群急性心肌梗死流行病学特点及预后的对比分析[J].中国现代医学杂志,2019,29(15):98-101.
[3]	徐雷,安少波,杜晓静,等.尿激酶原联合尼可地尔对STEMI患者急诊PPCI术后心肌灌注和功能的影响[J].江苏医药,2019,45(8):780-783.
[4]	中华医学会心血管病学分会,中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志,2015,43(5):380-393.
[5]	Faubert C,Heckman G,McKelvie R.Management of Non-ST-Elevation Myocardial Infarction in Elderly Patients:Time to Consider Frailty and Quality of Life[J].Can J Cardiol,2018,34(3):241-243.
[6]	Li J,Li X,Wang Q,et al.ST-segment elevation myocardial infarction in China from 2001 to 2011(the China PEACE-Retrospective Acute Myocardial Infarction Study):a retrospective analysis of hospital data[J].Lancet,2015,385(9966):441-451.
[7]	Burzotta F,Lassen JF,Banning AP,et al.Percutaneous coronary intervention in left main coronary artery disease:the 13th consensus document from the European Bifurcation Club[J].EuroIntervention,2018,14(1):112-120.
[8]	王山,张优,高传玉,等.休克指数对急性ST段抬高型心肌梗死患者院内死亡的预测价值[J].中华实用诊断与治疗杂志,2019,33(9):849-852.
[9]	冉迅,杜荣生,俞静,等.CTRP1与急性ST段抬高心肌梗死患者急诊PCI治疗出院后短期死亡的相关性[J].临床急诊杂志,2016,17(12):905-908.
[10]	刘志远,张金盈,刘江波,等.经靶向灌注导管冠状动脉内尿激酶原溶栓治疗STEMI的效果及预后观察[J].临床心血管病杂志,2019,35(4):339-343.
[11]	Kim Y,Ahn Y,Cho MC,et al.Current status of acute myocardial infarction in Korea[J].Korean J Intern Med,2019,34(1):1-10.
[12]	康文,王龙,王倩文,等.神经调节蛋白-1对脓毒症大鼠心肌血管内皮和心脏功能的影响[J].临床急诊杂志,2019,20(7):521-527.
[13]	陈继舜,刘晓唤,钱航,等.Gensini评分和HsCRP在预测PCI术后支架内再狭窄的价值[J].西安交通大学学报(医学版),2018,39(3):336-340.
[14]	邵晓萍,孙亚召,白春林.尿酸对急性ST段抬高型心肌梗死介入治疗患者远期预后的影响[J].中华老年心脑血管病杂志,2019,21(6):612-614.